Search in:

Ocular Immunology and Inflammation Volume 30, 2022 - Issue 6

Submit an article Journal homepage

143

Views

CrossRef citations to date

Altmetric

Original Articles

Outcomes of Repository Corticotropin Gel for Ocular Sarcoidosis

Daniel J. Oha Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, USA;b Columbia University Irving Medical Center, Edward S. Harkness Eye Institute, New York-Presbyterian Hospital, New York, New York, USA;c Vitreous, Retina, Macula Consultants of New York, New York, New York, USAView further author information

, MD,

Arjun Singha Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, USAView further author information

, BS,

Levi N. Kanua Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, USAView further author information

, MD,

Ann-Marie Lobo-Chana Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, USAView further author information

, MD, MS,

Peter W MacIntosha Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, USAView further author information

, MD &

Pooja Bhata Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, USACorrespondence[email protected]
View further author information

, MD

Pages 1420-1424 | Received 31 Jul 2020, Accepted 25 Jan 2021, Published online: 07 Apr 2021

Cite this article
https://doi.org/10.1080/09273948.2021.1884887
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Schimmer BP, Funder W. Adrenocorticotropic hormone, adrenal steroids, and the adrenal cortex. In: Brunton LL, Hilal-Dandan R, Knollmann BC, eds. Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e. McGraw-Hill. https://accessmedicine-mhmedical-com.proxy.cc.uic.edu/content.aspx?bookid=2189ionid=172482605. Accessed February 22, 2021.
Google Scholar
U.S. Food and Drug Administration. Drug approval package. H.P. Acthar Gel (repository corticotropin) injection. Silver Spring, MD: U.S. Food and Drug Administration; 2011. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022432Orig1s000Approv.pdf. Accessed July 21, 2020.
Google Scholar
Sharon Y, Chu DS. Adrenocorticotropic hormone gel for patients with non-infectious uveitis. Am J Ophthalmol Case Rep. 2019;15:100502. doi:10.1016/j.ajoc.2019.100502.
PubMedGoogle Scholar
Agarwal A, Hassan M, Sepah YJ, Do DV, Nguyen QD. Subcutaneous repository corticotropin gel for non-infectious panuveitis: reappraisal of an old pharmacologic agent. Am J Ophthalmol Case Rep. 2016;4:78–82. doi:10.1016/j.ajoc.2016.09.004.
PubMedGoogle Scholar
Fleischmann R, Furst DE. Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. Jun 2020;16:1–10.
Google Scholar
Chopra I, Qin Y, Kranyak J, et al. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records. Ther Adv Respir Dis. 2019 Jan-Dec;13:17. doi:10.1177/1753466619888127.
Web of Science ®Google Scholar
Aggarwal R, Marder G, Koontz DC, Nandkumar P, Qi Z, Oddis CV. Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis. Ann Rheum Dis. 2018 May;77(5):720–727. doi:10.1136/annrheumdis-2017-212047.
PubMed Web of Science ®Google Scholar
Mochizuki M, Smith JR, Takase H, et al. Revised criteria of international workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418–1422. doi:10.1136/bjophthalmol-2018-313356.
PubMed Web of Science ®Google Scholar
Clemson CM, Yost J, Taylor AW. The role of alpha-MSH as a modulator of ocular immunobiology exemplifies mechanistic differences between melanocortins and steroids. Ocul Immunol Inflamm. 2017;25:179–189. doi:10.3109/09273948.2015.1092560.
PubMed Web of Science ®Google Scholar
Ottaviani E, Franchini A, Genedani S. ACTH and its role in immune-neuroendocrine functions. A comparative study. Curr Pharm Des. 1999;5:673–681.
PubMed Web of Science ®Google Scholar
Catania A, Gatti S, Colombo G, et al. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev. 2004;56(1):1–29. doi:10.1124/pr.56.1.1.
PubMed Web of Science ®Google Scholar
Taylor AW, Kaplan HJ. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis. Ocul Immunol Inflamm. 2010;18:488–492. doi:10.3109/09273948.2010.525730.
PubMed Web of Science ®Google Scholar
Arnason BG, Berkovich R, Catania A, et al. Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult Scler. 2013;19(2):130–136. doi:10.1177/1352458512458844.
PubMed Web of Science ®Google Scholar
Wills AB, Adjemian J, Fontana JR, et al. Sarcoidosis-associated hospitalizations in the United States, 2002 to 2012. Ann Am Thorac Soc. 2018;15:1490–1493. doi:10.1513/AnnalsATS.201806-401RL.
PubMed Web of Science ®Google Scholar
Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020 Sep;26(5):527–534. doi:10.1097/MCP.0000000000000715.
PubMed Web of Science ®Google Scholar
https://data.census.gov/cedsci/table?q=ZCTA5%2060612%20Race%20and%20Ethnicity&tid=ACSDT5Y2018.B02001&hidePreview=false. Accessed October 26, 2020.
Google Scholar
https://data.census.gov/cedsci/table?q=ZCTA5%2060612%20Income%20and%20Poverty&tid=ACSST5Y2018.S1901&hidePreview=false Accessed October 26, 2020.
Google Scholar
https://www.huduser.gov/portal/datasets/il/il2018/2018summary.odn Accessed October 26, 2020.
Google Scholar
Hartung DM, Johnston K, Cohen DM, Nguyen T, Deodhar A, Bourdette DN. Industry payments to physician specialists who prescribe repository corticotropin. JAMA Netw Open. 2018;1(2):e180482. doi:10.1001/jamanetworkopen.2018.0482.
PubMed Web of Science ®Google Scholar
Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492–513. doi:10.1016/S0002-9394(00)00659-0.
PubMed Web of Science ®Google Scholar
Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014 Mar;121(3):785–96.e3. doi:10.1016/j.ophtha.2013.09.048.
PubMed Web of Science ®Google Scholar
Nelson WW, Lima AF, Kranyak J, et al. Retrospective medical record review to describe use of repository corticotropin injection among patients with uveitis in the United States. J Ocul Pharmacol Ther. 2019;35(3):182–188. doi:10.1089/jop.2018.0090.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Outcomes of Repository Corticotropin Gel for Ocular Sarcoidosis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Outcomes of Repository Corticotropin Gel for Ocular Sarcoidosis

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date